BGB-283, a Novel RAF Kinase and EGFR inhibitor, Displays Potent Antitumor Activity in B-RAF Mutated Colorectal Cancers

Tang, Z.; Yuan, X.; Du, R.; Cheung, S.-H.; Zhang, G.; Wei, J.; Zhao, Y.; Feng, Y.; Peng, H.; Zhang, Y.; Du, Y.; Hu, X.; Gong, W.; Liu, Y.; Gao, Y.; Liu, Y.; Hao, R.; Li, S.; Wang, S.; Ji, J.-f.; Zhang, L.-H.; Li, S.; Sutton, D.; Wei, M.; Zhou, C.; Wang, L.; Luo, L.

期刊名称Molecular Cancer Therapeutics
作者Tang, Z.; Yuan, X.; Du, R.; Cheung, S.-H.; Zhang, G.; Wei, J.; Zhao, Y.; Feng, Y.; Peng, H.; Zhang, Y.; Du, Y.; Hu, X.; Gong, W.; Liu, Y.; Gao, Y.; Liu, Y.; Hao, R.; Li, S.; Wang, S.; Ji, J.-f.; Zhang, L.-H.; Li, S.; Sutton, D.; Wei, M.; Zhou, C.; Wang, L.; Luo, L.
印刷ISSN1535-7163
电子ISSN1538-8514
文件大小8891.06KB
发表时间2015-07-24
DOI10.1158/1535-7163.mct-15-0262

发现好书期刊，享受阅读乐趣

BGB-283, a Novel RAF Kinase and EGFR inhibitor, Displays Potent Antitumor Activity in B-RAF Mutated Colorectal Cancers